K-V Pharmaceutical records $242,000 of operating income for November

By Caroline Salls

Pittsburgh, Dec. 18 - K-V Pharmaceutical Co. reported $242,000 of operating income for November on $6.25 million in net revenues, according to its monthly operating report filed Monday with the U.S. Bankruptcy Court for the Southern District of New York.

The figures showed a decline from the $624,000 of operating income posted for October on $7.73 million in net revenues.

The net loss from continuing operations for November was $3.19 million, widening from a $1.89 million net loss from continuing operations for October.

In addition, K-V had $26.74 million in cash and cash equivalents at Nov. 30, down from $28.41 million at the end of October.

K-V Pharmaceutical, a St. Louis specialty pharmaceutical company, filed for bankruptcy on Aug. 4. The Chapter 11 case number is 12-13346.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.